Molecular profiling confirms historical immunohistochemistry in acromegaly

in Endocrine-Related Cancer
Authors:
Sylvia L Asa Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio, USA

Search for other papers by Sylvia L Asa in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0001-8418-5054
and
Shereen Ezzat Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada

Search for other papers by Shereen Ezzat in
Current site
Google Scholar
PubMed
Close

Correspondence should be addressed to S L Asa: Sylvia.Asa@UHhospitals.org
Restricted access
Rent on DeepDyve

Sign up for journal news

 

  • Collapse
  • Expand
  • Asa SL & Perry A 2020 Tumors of the Pituitary Gland, AFIP Atlas of Tumor and Non-tumor Pathology, Series 5. Arlington, VA, USA: ARP Press.

  • Asa SL, Kucharczyk W & Ezzat S 2017 Pituitary acromegaly: not one disease. Endocrine-Related Cancer 24 C1C4. (https://doi.org/10.1530/ERC-16-0496)

  • Bhayana S, Booth GL, Asa SL, Kovacs K & Ezzat S 2005 The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. Journal of Clinical Endocrinology and Metabolism 90 62906295. (https://doi.org/10.1210/jc.2005-0998)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Ezzat S, Kontogeorgos G, Redelmeier DA, Horvath E, Harris AG & Kovacs K 1995 In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide. European Journal of Endocrinology 133 686690. (https://doi.org/10.1530/eje.0.1330686)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Ezzat S, Caspar-Bell GM, Chik CL, Denis MC, Domingue , Imran SA, Johnson MD, Lochnan HA, Grégoire Nyomba BL, Prebtani A, et al.2019 Predictive markers for postsurgical medical management of acromegaly: a systematic review and consensus treatment guideline. Endocrine Practice 25 379393. (https://doi.org/10.4158/EP-2018-0500)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Puig-Domingo M, Gil J, Sampedro-Nunez M, Jorda M, Webb SM, Serra G, Pons L, Salinas I, Blanco A, Marques-Pamies M, et al.2020 Molecular profiling for acromegaly treatment: a validation study. Endocrine-Related Cancer 27 375389. (https://doi.org/10.1530/ERC-18-0565)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N & Kudo E 2007 Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Modern Pathology 20 12691277. (https://doi.org/10.1038/modpathol.3800965)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Sano T, Rong QZ, Kagawa N & Yamada S 2004 Down-regulation of E-cadherin and catenins in human pituitary growth hormone-producing adenomas. Frontiers of Hormone Research 32 127132. (https://doi.org/10.1159/000079041)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • Xu B, Sano T, Yoshimoto K & Yamada S 2002 Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocrine Pathology 13 341351. (https://doi.org/10.1385/ep:13:4:341)

    • PubMed
    • Search Google Scholar
    • Export Citation